Loading stock data…
Bruker Corporation (BRKR)
$58.37-0.13 (-0.22%)
Market ClosedLast close Sep 8
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Bruker Corporation in the Healthcare sector is trading at $58.37 with a market capitalization of $8.6B. Wall Street consensus targets $58.75 (12 analysts), implying a +0.7% move over the next 12 months. The stock is currently near its 52-week high of $65.30, remaining 21.7% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side consensus broadly in line with current price
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $838.50M↑ | $823.40M↓ | $977.20M↑ | $860.50M↑ | $797.40M |
| Gross Profit | $416.00M↑ | $379.80M↓ | $449.20M↑ | $379.40M↑ | $357.90M |
| Operating Income | $82.80M↑ | $36.40M↓ | $111.80M↑ | $35.00M↑ | $26.30M |
| Net Income | -$52.00M↓ | $14.40M↓ | $26.00M↑ | -$59.60M↓ | $7.60M |
Peer Comparison
JNJUNHPFE
Fundamentals
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BS...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.59B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.34%
ROE
Average efficiency. Growth may require heavy reinvestment.
-0.47%
Volume
Today's trading volume
1.03M
Recent News
Bruker (BRKR) Wagers On Fusion Energy While Wall Street Waits
On September 4, Bruker (NASDAQ:BRKR) said its energy and supercon technologies unit, Bruker Energy & Supercon Technologies (or BEST), had struck a supply collaboration with Luvata Materials & Solutions to scale up production of RRP superconductors for magnetic confinement fusion. The deal lands right as governments and private developers from Europe to South Korea race […]
Why Is Bruker (BRKR) Up 12.5% Since Last Earnings Report?
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Small-Cap Stocks We’re Skeptical Of
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.
Research Tools & Consumables Stocks Q2 Highlights: Bruker (NASDAQ:BRKR)
Let’s dig into the relative performance of Bruker (NASDAQ:BRKR) and its peers as we unravel the now-completed Q2 research tools & consumables earnings season.
3 Unpopular Stocks with Questionable Fundamentals
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.